Identifying Potential Drug Targets and Biomarkers for NCF1C (G654817)

Target Name: NCF1C

NCBI ID: G654817

NCF1C

Other Name(s): SH3PXD1C | Neutrophil cytosolic factor 1C pseudogene | neutrophil cytosolic factor 1C pseudogene

Identifying Potential Drug Targets and Biomarkers for NCF1C

NCF1C (SH3PXD1C), also known as SCL/TAL1, is a non-coding RNA molecule that plays a critical role in the regulation of cell proliferation and survival. It has been shown to be involved in a wide range of physiological processes, including cell growth, differentiation, and response to environmental stimuli.

In recent years, researchers have been increasingly interested in identifying potential drug targets and biomarkers for NCF1C. This is because the faulty or abnormal gene expression levels can serve as disease treatment targets. This is because when a gene expression level is abnormally high or low, it usually means that the gene is overactivated or overrepressed in some way, which provides an opportunity to design specific drugs.

NCF1C has been shown to play a key role in the regulation of cell proliferation and survival. It has been shown to be involved in the development and maintenance of cancer, as well as in the regulation of cellular processes such as cell adhesion, migration, and invasion.

In addition, NCF1C has also been shown to play a key role in the regulation of stem cell maintenance and proliferation. It has been shown to be involved in the stem cell self-renewal and in the regulation of stem cell differentiation.

Furthermore, NCF1C has been shown to play a key role in the regulation of tissue repair and regeneration. It has been shown to be involved in the regulation of tissue repair and regeneration after injury or disease, including the regulation of cell proliferation and the formation of new tissues.

In addition, NCF1C has also been shown to play a key role in the regulation of immune cell function and response to infection. It has been shown to be involved in the regulation of immune cell function, including the regulation of T cell development and activation, as well as the regulation of immune cell responses to infection.

Overall, NCF1C is a promising drug target and biomarker for a wide range of diseases, including cancer, stem cell diseases, tissue repair and regeneration, and immune system disorders. Further research is needed to fully understand the role of NCF1C in these processes and to develop effective treatments.

Protein Name: Neutrophil Cytosolic Factor 1C Pseudogene

Functions: May be required for activation of the latent NADPH oxidase (necessary for superoxide production)

The "NCF1C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NCF1C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets